Unknown

Dataset Information

The Neutralizing Face of Hepatitis C Virus E2 Envelope Glycoprotein.


ABSTRACT: The high genetic variability of hepatitis C virus, together with the high level of glycosylation on the viral envelope proteins shielding potential neutralizing epitopes, pose a difficult challenge for vaccine development. An effective hepatitis C virus (HCV) vaccine must target conserved epitopes and the HCV E2 glycoprotein is the main target for such neutralizing antibodies (NAbs). Recent structural investigations highlight the presence of a highly conserved and accessible surface on E2 that is devoid of N-linked glycans and known as the E2 neutralizing face. This face is defined as a hydrophobic surface comprising the front layer (FL) and the CD81 binding loop (CD81bl) that overlap with the CD81 receptor binding site on E2. The neutralizing face consists of highly conserved residues for

SUBMITTER: Tzarum N 

PROVIDER: S-EPMC6008530 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature